https://www.optimumcomms.com/wp-content/uploads/2023/10/Mission_Therapeutics_Logo_300x180px-80x80Web_Logos-1.png
180
300
Marketing Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Marketing Team2023-12-05 08:55:092023-12-05 08:56:47Mission Therapeutics granted MHRA Clinical Trial Authorisation (CTA) for MTX325 for the treatment of Parkinson’s Disease
https://www.optimumcomms.com/wp-content/uploads/2023/10/Mission_Therapeutics_Logo_300x180px-80x80Web_Logos-1.png
180
300
Marketing Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Marketing Team2023-12-05 08:55:092023-12-05 08:56:47Mission Therapeutics granted MHRA Clinical Trial Authorisation (CTA) for MTX325 for the treatment of Parkinson’s Disease
The first six companies enter the Deep Tech Lab – Quantum start-up accelerator at BII to unlock the potential in quantum science
BioInnovation Institute (BII), an international non-profit foundation…

Poolbeg Pharma plc – Directorate Change
30 November 2023 - Poolbeg Pharma (AIM: POLB, OTCQB: POLBF,…

Highly experienced CDMO expert Michel Spagnol appointed Chairman of Astraveus
Paris, France, 28 November, 2023 – Astraveus SAS (“Astraveus”…

Kaleido launches cutting-edge Hybrid Closed Loop system with Diabeloop and Dexcom for people with diabetes
Kaleido is one of the world's…

Poolbeg Pharma – Immunomodulator II patent granted in Japan
21 November 2023 - Poolbeg Pharma (AIM: POLB, OTCQB: POLBF,…

Biocomposites expands its product portfolio with the launch of SYNICEM™ spacers in the UK
SYNICEM™ hip, knee and shoulder spacers are preformed…

Poolbeg Pharma – POLB 001 LPS Challenge Trial Data to be Presented at IUIS
POLB 001 - a potential blockbuster immunomodulator
16 November…

Versameb Announces FDA Clearance of IND Application for VMB-100 in the Treatment of Stress Urinary Incontinence
Versameb AG (“Versameb”), a pre-clinical stage company focused…
https://www.optimumcomms.com/wp-content/uploads/2023/11/IO-Biotech.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-11-13 13:22:592023-11-16 09:22:20IO Biotech Announces 2023 Third Quarter Results
IO Biotech Appoints Helen Collins, MD, to its Board of Directors
NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq:…

Mission Therapeutics announces publication in Nature Communications outlining potential of experimental drug MTX325 as a disease-modifying therapy for Parkinson’s Disease
International research collaboration between Harvard Medical…

Oxolife Appoints International Fertility Experts to its Scientific Advisory Board
Leading experts in fertility and human reproduction with…

Pharmaceutical distributor Mawdsleys unveils its expanded third-party logistics (3PL) warehouse in Doncaster – bigger and greener than before
Rt Hon Ed Miliband, Labour MP for Doncaster North and Shadow…

IO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanoma
Trial expected to reach the primary endpoint of progression…

Poolbeg Pharma plc – Key Senior Members of Former Amryt Pharma Leadership Team join Poolbeg Pharma
Poolbeg team boosted by highly experienced executives with track…

Lytix Biopharma presents third quarter 2023 results
Oslo, 09 November 2023. Lytix Biopharma AS (“Lytix”) (Euronext…

IO Biotech Announces Participation in Upcoming Investor Conferences
NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq:…

Lytix Biopharma presenting at major investor conferences in London and Stockholm in November
Oslo, 8 November 2023. Lytix Biopharma AS (“Lytix”) (Euronext…

Vicore to Present at the Stifel 2023 Healthcare Conference
Stockholm, November 7, 2023 – Vicore Pharma Holding AB…
We’d love to hear from you.
For more information about Optimum Strategic Communications, please get in touch.
Optimum Strategic Communications’ specialist team has an in-depth understanding of how to communicate complex science to investors and corporate stakeholders. Optimum helps life science companies on their journey as they grow and has been trusted by hundreds of healthcare clients from around the world, both public and private, large and small.
Locations
- London
- Amsterdam
- Stockholm
- Zurich
- New York